IL6 and inflammatory bowel disease: Increased numbers of activated immune cells are present in the intestinal mucosa of IBD patients, resulting in enhanced cytokine levels of tumor necrosis factor-α and interleukins (IL), such as IL-6, IL-17, IL-10 [1], and IL-8 [2].